Author Guidelines

IPA follows the international regulations against scientific misconduct including fabrication, falsification, plagiarism, and etc. Any cases of suspected misconduct will be assessed during the peer-review and publication process based on COPE guidelines.

1-Title page

(The following items are required on the title page)

Manuscript title: Each word in the title should start with capital letter except for the conjunctions, articles, and prepositions. The font of the title should be Times New Roman, 14 pt, bold and not italic.

Titles should be concise, specific, and informative and should contain the key points of the work and questions and declarative sentences should be avoided.

Running title:a short version of the title (up to 40 characters including spaces) in Title format and font.

Authors:List authors in the order in which they are to appear in the byline of the article(font: Times New Roman, 12 pt, not bold, not italic)(First name Middle name Last name).

Authors should be identified by superscripts and corresponded to the related affiliation. Additionally, put an asterisk in front of the name of the corresponding author.For example:

GuobaoWei^a, Peter X. Ma^b, c,*

Authors' Affiliations:The font of authors' affiliations should be Times New Roman, 12 pt, italic, not bold.For example:

^a Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109-2009, USA; ^b Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109-1078, USA;^c Macromolecular Science and Engineering Center, University of Michigan, Ann Arbor, MI 48109-1055, USA

*Corresponding author: Following information is needed;

First name Middle name Last name; Academic degree; Affiliation

Tel; Fax; Email; and Mailing address.

The corresponding author is the one individual of authorship group who takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that requirements requested by the journal are properly completed. Also, the corresponding author should be available after publication to respond to critiques of the work. For example:

*Corresponding author:Peter X. Ma; PhD; Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109-1078, USA; Macromolecular Science and Engineering Center, University of Michigan, Ann Arbor, MI 48109-1055, USA

Tel +1-734-764-2209

Fax +1-734-647-2110

E-mail: mapx@umich.edu

Mailing address:

*Introduce 3-5 reviewers end of the title page with their Email and Phone numbers. 

2-Cover letter

Delete the text in green color and replace it with your own text if any.

Cover letter

To,

 Editor-in-chief, IPA

 [Insert data here —Day Month Year]

Re: submission of Manuscript to International Pharmacy Acta for publication

Dear Editor,

 I/We would like my/our submitted manuscript entitled "[insert title of your manuscript here]" to be considered for publication in your journal [insert journal name here] as a [insert article type here for example, original research article, systematic review, meta-analysis, clinical trial].

I/We hereby confirm that I/we have studied IPA Author Guidelines and Ewe confirm that the submission follows all IPA terms and conditions for manuscript, and Ewe authors of the above mentioned manuscript accept all of IPA regulations in this regards.

 [Briefly explain the content presented in this manuscript in your own word including the significance of your work and novelties presented in your work.] Please state any potential conflict of interest such as 1) funding and financial connections and support, including any resources that any of this manuscript co-authors might have received directly and indirectly for this job or publication, and 2) any personal relationship, rivalries, academic competition and 3) any intellectual properties. In case of the lack of any kind of conflicts of interests for any of co-authors mentioned in this manuscript, please state `nil' or `none declared.'

 We give the rights to [insert corresponding author's name] who on behalf of all co-authors will communicate with IPA from this point onward and will make necessary changes as per the IPA requests. So please address all correspondence to: [Insert contact address, telephone and fax numbers, and e-mail address of corresponding author]

3-Abstract

Untitled Document

Each article type follows a specific difference in Abstract format.

• Structured Abstracts: It should be generally structured into the subsections. Details for different article types are specified below. The title of each subsection should be written in bold, not italic, 12 pt Times New Roman font on a separate line at the beginning of that line. If a required subsection does not apply, please write "not applicable"
• Unstructured Abstracts: Review articles contains an unstructured abstract.

Fundings: Funding sources should be listed separately after the Abstract to facilitate proper display and indexing for search retrieval by MEDLINE.

Keywords: 3 to 10 key words or phrases that author believes are representative of main content of the article. It is recommended to select these words from the medical subject headings list of nlm.nih.gov/mesh (MeSH terms) but they can be of the authors' own choice.

4-Blinded Manuscript text

In general, titles should be in bold, not italic, 12 pt Times New Roman fonts and subtitles in not bold, italic 12pt Times New Roman fonts. However, each article type follows specific differences in format as listed below:

 Original Research Article

Below sections can be divided into headed subsections.

1. Introduction

This section should provide a background and rationale of the article with regard to current knowledge included a summary of the literature to indicate how and why the study purpose or hypothesis was developed. The section should end with a brief statement of what is being reported in the article.

1. Subtitle
2. Subtitle

2. Materials and Methods

This section should be clarity about how and why a study was done in a particular way. Each method must be briefly described and appropriately referenced in the main article. Thedates and period of study should be stated, as well as mention of institutional review board or ethics committee approval.Protocols of new or not well known methodologies should be provided in details. Statistical methods and employed specific computer programs should also be mentioned with reference to the full address and version of the software used. To reduce a lengthy "Materials and Methods" section, experimental details may be included in Supporting Information file.

3. Results

Present your results in logical sequence in the text, tables, and figures. Do not repeat all the data in the tables or figures in the text. The results reported in the manuscript should be specific and relevant to the research purpose or hypothesis. Give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical significance attached to them, if any. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables.

Discussion and Conclusions

This section should be the critical consideration and examination of the study.

The study purpose or hypothesis should be addressed in this section, and the results should be compared and interpreted with regard to the findings of other studies.

 The study's limitations and the generalizability of the results should be discussed. This section should end with a clear, concise conclusion that does not go beyond the findings of the study. Types of future studies needed, if appropriate, should be mentioned.

5-Tables and Table Titles

Please start this component on a new page. Each table should be presented on separate page in 1.5 space word table format. Do not embed tables as graphic files. Each column should have a heading and the units of measurement should be given in parentheses in the heading. Obtain written permission to reproduce previously published tabular material. Signed permission forms must be sent to the IPA Editorial Office upon submissions.

Table 2. The table number should be followed by a brief descriptive title at the top of table in bold text(in bold, not italic, 12 pt Times New Roman font):In the following insert table legend if any (in not bold, not italic, 12 pt Times New Roman font)

• Number tables consecutively with Arabic numerals.

• If a table exceeds one manuscript page, include table number, ''continued,'' and table headings on each page.
  
  

Table 2. Continued

Abbreviations:

6-Figure/Illustrations and their Legends

• Figures and line art should be provided only as TIFF, BMP, JPEG, GIF, PNG,  EPS, PSD or Post Script preferably from PhotoShop or Illustrator software. The best formats are TIFF and JPEG.
• Electronically submitted figures should be of high resolution:

• Color, 300 d.p.i. minimum; we prefer RGB for optimal rendering online, and, if possible, recommend that authors use sRGB IEC61966-2.1 when preparing files
• Grayscale, 600 d.p.i. minimum for blots and black & white photographs
• Line art, 1200 d.p.i. minimum for graphs and illustrations

• Histograms should be presented in a simple, two-dimensional format, with no background grid.
• Any lettering in the figures should be large enough to stand photographic reduction and use 9-pt to 12-pt Helvetica or Arial font for them.
• Mask any patient identification in photographs; otherwise, a signed permission statement is required for identifiable patients (please see Permissions section).
• Figures should be on a white background. Do not use overall backgroundshading in figures. Do not use gray-shaded bars in graphs—use bars with solid, open, or hatched fill.
• Please start embedding figures on new page of Microsoft Word manuscript document and call out all figures in the text. Number all figures sequentially with Arabic numerals in the order cited in the text e.g.Figure 1.

Figures with multiple parts should be labeled and referred to as (a), (b), (c), etc.  Authors should prepare their figures for either one column width (80mm) or the entire page width (16mm). The maximum height is 10mm.

• IPAreserves the right to resize and/or crop figures to fit the journal's format where appropriate. Authors will see a proof of figures.

• Specific clinical study designs flow diagram should be embedded as Figure 1.

Figure Legends

• Figure 1.5 spaced legends should be started on new page of manuscript document. Figure legends should include the figure number, a brief title for the whole figure in bold 12 pt Times New Roman font and a brief description of the figure in not bold 12 pt Times New Roman font. Figures with multiple parts should be labeled and referred to as (a), (b), (c), etc. For example:
• Figure 2.Histological featuresThe normal histological features of NS or simvastatin 4mg/kg + cisplatin isolated kidneys. (a) magnification: 100 x.  (b) magnification: 250 x.
• Obtain written permission to reproduce previously published figures. Credits for the reproduced work are included in the figure legend. Signed permission forms must be sent to the IPA Editorial Office upon submission.

7- References

General Considerations

• Authors are responsible for the accuracy and completeness of their references and for correct text citation
• Reference to a paper accepted but not yet published can be listed as ''In press" .Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source.

Style and Format

Cite references in the text, tables or figure legends, by Arabic numerals in brackets consecutively in the order appeared for first time in manuscript manually.  Reference numbers in the text should be inserted immediately after punctuation (with no word spacing).

Where more than one reference is cited, these should be separated by a comma, for example: [2,3,4]

 For sequences of consecutive numbers, give the first and last number of the sequence separated by a hyphen, for example: [5-7]

References should follow the instructions offered by The NLM Style Guide for Authors, Editors, and Publishers and you can find sample references in webpage

http://www.nlm.nih.gov/bsd/uniform_requirements.html.

 Details are in Citing Medicine(at http://www.nlm.nih.gov/citingmedicine). Style files are available for use with bibliographic management software EndNote style file.

• Begin the 1.5 spacedreference liston a new page of manuscript document.
• Provide names of all authors in a reference.
• The titles of journals should be abbreviated according to the style used for MEDLINE (www.ncbi.nlm.nih.gov/nlmcatalog/journals)and should be in italics and page numbers should be fully written out.

Standard journal article

Authors. Article Title. Journal Title. Date of publication: Volume (Issue): Location (pagination)

Eg1: Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.

Eg2: Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.

Article not in English

Eg3: Ellingsen AE, Wilhelmsen I. Sykdomsangstblantmedisin- ogjusstudenter. TidsskrNorLaegeforen. 2002;122(8):785-7. Norwegian.

Books

Authors. Title. Edition. Secondary author. Place of Publication. Publisher, Date of Publication. Total number of pages.

Eg4: Belitz HD, Grosch W, Schieberle P. Food chemistry. 3rd rev. ed. Burghagen MM, translator. Berlin: Springer; 2004. 1070 p.

Dissertations and Theses

Authors. Title [Book type]. [Place of Publication]: Publisher;Date. Total number of pages.

Eg5: Kempner JL. Aching heads, making medicine: gender and legitimacy in headache [dissertation]. [Philadelphia]: University of Pennsylvania; 2004. 271 p.

Journals on the Internet

Authors. Article Title. Journal Title [Type of Medium]. Date of Publication [Date of Citation]: Volum Number(Issue Number): Location

Eg6: Kaul S, Diamond GA. Good enough: a primer on the analysis and interpretation of noninferiority trials. Ann Intrrn Med [Internet]. 2006 Jul 4 [cited 2007 Jan 4];145(1):62-9. Available from: http://www.annals.org/cgi/reprint/145/1/62.pdf

Patents

Inventors; Assignee. Title. Patent Country Document type Country Code, Patent Number. Date Issued.

Eg7: Myers K, Nguyen C, inventors; 3F Therapeutics, Inc., assignee. Prosthetic heart valve. United State patent US 6,911,043. 2005 Jun 28.

Forthcoming ("in press")

Authors. Article Title. Journal Title. Note.

Eg8: Polley DB, Cobos I, Merzenich MM, Rubenstein JL. Severe hearing loss in Dlx 1 mutant mice. Hear Res. Forthcoming 2006.

Databases/Retrieval Systems on the Internet

Authors: Title [Type of Medium]. Place of Publication: Publisher: Date of Publication [ Date of Updating/Revision; Date of citation]. Availability.

Eg9: Hooper JF. Psychiatry & the Law: Forensic Psychiatric Resource Page [Internet]. Tuscaloosa (AL): University of Alabama, Department of Psychiatry and Neurology ; 1999 Jan 1 [updated 2006 Jul 8; cited 2007 Feb 23]. Available from: http://bama.ua.edu/.

Conference proceedings:

Editors. Book Title. Conference Title; Date of Conference; Place of Conference; Place of Publication: Publisher; Date of Publication. Pagination.

Eg10:  Pacak K, Aguilera G, Sabban E, Kvetnansky R, editors. Stress: current neuroendocrine and genetic approaches. 8^th Symposium on Catecholamines and Other Neurotransmitters in Stress; 2003 Jun 28 – Jul 3; Smolenice Castle, Slovakia. New York: New York Academy of Sciences; 2004 Jun. 590p.

Conference paper:

Authors of Paper. Title of Paper. Connective Phrase: Editor of Proceedings, Conference Title; Date of conference; Place of Conference

Eg11:  Bengtsson S, Solheim BG. Enforcement of data Protection, Privacy and Security in Medical Informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors.MEDINFO 92.Proceedings of the 7^th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland.

8- Acknowledgements

This section of manuscript document should be started on new page and describe all relevant contributions of persons who have contributed to the work but are not a co-author on the manuscript.

Supporting information

This section is included the information which would help the editors or reviewers to better understand the work such as research protocol details and will undergo peer review with the rest of the manuscript but will not be copyedited or changed from its original format. If it is previously published, it must be submitted with the necessary permissions. For all Clinical Research Article and Systematic reviews and meta-analysis submissions, authors must include the following: 1.ticked checklist relevant to the research design they have used e.g. CONSORT checklist; 2.trial protocol; 3. a blank sample copy of any forms used in the trial.

Supporting information should be uploaded as Supplementary Files in Submission process.

Criteria for publication of prepared manuscript

• Originality of Manuscript & Plagiarism Checking: Manuscript submitted for publication must be original, previously unpublished and not accepted for publication (in press) in any format and/or language partially or totally, other than as short congress abstracts, and no part of the manuscript must be under consideration for publication elsewhere in any languages, until final decision is made by IPA on acceptance or rejection of it. Manuscripts submitted to the journal will be checked for originality by an experienced Plagiarism Committee and using anti-plagiarism software. The authors are responsible for the validity, integrity and completeness of the data without any fabrication or fraud and the precision and accuracy of the data analysis.

• Permissions and Ethics: This journal is follower of Committee on Publication Ethics (COPE) and ICMJE principles.

• Permissions of reproduction of another source:The manuscript must not infringe any personal and proprietary rights of others. Information or items such as figures, tables, or parts of text reproduced from another source must be properly cited. The copyright-holder's permission for previously published or copyrighted items, and provider's permission for items which is uncopyrighted or unpublished must have been obtained prior to submission and signed permission statements from the copyright holder or provider must be uploaded as Supplementary Files in Submission process.
• Ethic principles in Humans and Animals Experience : Human experiences must be performed in conformity with ethical principles involved in WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects or with similar principles in affiliated organization, and they must get the approval of the institutional ethics review board or Research Ethics committee of their affiliated organization before the beginning of the study. Animal experiences must follow WMA Statement on Animal Use in Biomedical Research or ICLAS – Ethics and Animal Welfare Committee-Ethical Guideline for Researchers and before the beginning of the study, the approval of Animal Experiments Ethics committee of their affiliated organization must be granted to them. So for manuscripts involving humans or animals data, approval letter granted by the institutional ethics committee must be accompanied with other publication requirements at the time of manuscript submission.

• Author and Non-Author Contribution: All authors must meet all four authorship criteria based on ICMJE recommendations. Contributors to the work who meet fewer than all 4 of the above authorship criteria for authorship should not be listed as authors. Inst

Criteria for publication of prepared manuscript

• Originality of Manuscript & Plagiarism Checking
• Permissions and Ethics
• Permissions of reproduction of another source
• Ethic principles in Humans and Animals Experience
• Author and Non-Author Contribution
• Conflicts of Interest and Fundings and Sources of support Declaration
• Patient Permission and Study Participant Consent:
• Authors´ Statement & Agreement Form